A cross‐sectional analysis of Alzheimer’s disease plasma biomarkers and gait variables in cognitively normal older adults

Documenti analoghi

• The association between measures of subjective cognitive decline and Alzheimer’s disease plasma biomarkers in cognitively normal individuals
  di: Mark A Bernard, et al.
  Pubblicazione: (2024)
• Increased blood‐brain barrier permeability following COVID‐19 and its correlation with Alzheimer's biomarkers
  di: Zhe Sun, et al.
  Pubblicazione: (2024)
• Increased blood‐brain barrier permeability following COVID‐19 and its correlation with Alzheimer’s biomarkers
  di: Zhe Sun, et al.
  Pubblicazione: (2024)
• Biomarkers for Alzheimer's disease to differentiate Normal, SCD, and MCI subjects and their correlation with cognitive dysfunction
  di: Allal Boutajangout, et al.
  Pubblicazione: (2025)
• Elevated Blood Biomarkers of Neurodegeneration and Blood Brain Barrier Dysfunction Correlate with Lower MRI Regional Brain Volumes Two Years after COVID‐19
  di: Jennifer A. Frontera, et al.
  Pubblicazione: (2024)